MacuLogix's Corporate Minority Round

MacuLogix raised a round of funding on July 18, 2017. Investors include Life Sciences Greenhouse of Central Pennsylvania.

MacuLogix is a provider in the early detection and tracking of age-related macular degeneration (AMD). MacuLogix' AdaptDx has received FDA 510(k) clearance for measurement of dark adaptation function …

Articles about MacuLogix's Corporate Minority Round: